FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia By Ogkologos - December 3, 2024 716 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up MOST POPULAR Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer October 26, 2021 First Global Estimates of Cervical Cancer Attributable to HIV November 30, 2020 Welcome to our new committee chairs November 22, 2022 Patient Guide in Prostate Cancer Now Available in Vietnamese December 10, 2025 Load more HOT NEWS PICOS Score May Help in Identification of Patients with Brain Metastasis... ‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges... El cáncer en mi comunidad: Ampliar el acceso a las pruebas... Immune Checkpoint Inhibitor Induced Thyroiditis Associated with a Large Reduction in...
